1. 3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC). (September 2015) Authors: Calvo, E.; López-Martin, J.A.; Bendell, J.; Eder, J.P.; Taylor, M.; Ott, P.A.; Pietanza, M.C.; Horn, L.; Jäger, D.; Braud, F. De; Morse, M.A.; Ascierto, P.A.; Le, D.T.; Amin, A.; Evans, J.; Simon, J.; Lin, C.S.; Christensen, O.; Antonia, S.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Caimi, P.F.; Eder, J.P.; Jacobsen, E.D.; Jacobson, C.A.; LaCasce, A.S.; Shipp, M.A.; Chapuy, B.; Labriola‐Tomphins, E.; Boisserie, F.; Passe, S.; Chesné, E.; Pierceall, W.; Zhi, J.; DeMario, M.; Vaishampayan, U.; Dowlati, A.; Shapiro, G.I.; Fisher, D.C.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors. (October 2022) Authors: Meric-Bernstam, F.; Eder, J.P.; Vandross, A.; Gara, M.; Gayle, S.; Pearson, P.; DeCillis, A.; Tolcher, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗